CAVATAK (CVA21) in Non-muscle Invasive Bladder Cancer (VLA-012 CANON)
Condition(s):Non-muscle Invasive Bladder CancerLast Updated:July 27, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Non-muscle Invasive Bladder CancerLast Updated:July 27, 2022Completed
Condition(s):DacryocystitisLast Updated:February 13, 2014Completed
Condition(s):Unspecified Adult Solid Tumor, Protocol SpecificLast Updated:August 9, 2012Completed
Condition(s):Open Angle GlaucomaLast Updated:February 25, 2016Terminated
Condition(s):Superficial Bladder CancerLast Updated:February 13, 2024Recruiting
Condition(s):Bladder CancerLast Updated:December 31, 2018Unknown status
Condition(s):Urinary Bladder Neoplasms; Urologic Neoplasms; Neoplasms; Urinary Bladder Diseases; Urologic DiseasesLast Updated:September 8, 2016Completed
Condition(s):KeratoconusLast Updated:February 28, 2023Terminated
Condition(s):GlaucomaLast Updated:March 29, 2011Completed
Condition(s):GlaucomaLast Updated:October 13, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.